(Q35617543)

English

Mizoribine provides effective treatment of sequential histological change of arteritis and reduction of inflammatory cytokines and chemokines in an animal model of Kawasaki disease

scientific article published on 29 September 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

Mizoribine provides effective treatment of sequential histological change of arteritis and reduction of inflammatory cytokines and chemokines in an animal model of Kawasaki disease (English)

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

author name string

Kei Takahashi

1

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

Toshiaki Oharaseki

2

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

Tomokazu Nagao

3

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

Yuki Yokouchi

4

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

Hitomi Yamada

5

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

Noriko Nagi-Miura

6

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

Naohito Ohno

7

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

Tsutomu Saji

8

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

Tomio Okazaki

9

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

Kazuo Suzuki

10

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

publication date

29 September 2011

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

Pediatric Rheumatology Online Journal

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

9

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

30

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

https://scigraph.springernature.com/pub.10.1186/1546-0096-9-30

0 references

Infliximab for intravenous immunoglobulin resistance in Kawasaki disease: a retrospective study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3239324

12 July 2018

Epidemiologic features of Kawasaki disease in Japan: results of the 2007-2008 nationwide survey

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3239324

12 July 2018

Primary treatment of incomplete Kawasaki disease with infliximab and methylprednisolone in a patient with a contraindication to intravenous immune globulin

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3239324

12 July 2018

Infliximab treatment of intravenous immunoglobulin-resistant Kawasaki disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3239324

12 July 2018

Ulinastatin therapy in kawasaki disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3239324

12 July 2018

Re-treatment regimens for acute stage of Kawasaki disease patients who failed to respond to initial intravenous immunoglobulin therapy: analysis from the 17th nationwide survey

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3239324

12 July 2018

Prediction of intravenous immunoglobulin unresponsiveness in patients with Kawasaki disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3239324

12 July 2018

Coronary risk factors in Kawasaki disease treated with additional gammaglobulin

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3239324

12 July 2018

Infliximab as a novel therapy for refractory Kawasaki disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3239324

12 July 2018

The immunosuppressive agent mizoribine monophosphate forms a transition state analogue complex with inosine monophosphate dehydrogenase

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3239324

12 July 2018

Response of refractory Kawasaki disease to pulse steroid and cyclosporin A therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3239324

12 July 2018

Corticosteroids in the treatment of the acute phase of Kawasaki disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3239324

12 July 2018

Mizoribine and mycophenolate mofetil

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3239324

12 July 2018

Treatment of immune globulin-resistant Kawasaki disease with pulsed doses of corticosteroids

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3239324

12 July 2018

Gamma globulin re-treatment in Kawasaki disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3239324

12 July 2018

Genetic and biochemical studies on the activation and cytotoxic mechanism of bredinin, a potent inhibitor of purine biosynthesis in mammalian cells.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3239324

12 July 2018

A new infantile acute febrile mucocutaneous lymph node syndrome (MLNS) prevailing in Japan.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3239324

12 July 2018

Guanine ribonucleotide depletion inhibits T cell activation. Mechanism of action of the immunosuppressive drug mizoribine

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3239324

12 July 2018

High regression rate of coronary aneurysms developed in patients with immune globulin-resistant Kawasaki disease treated with steroid pulse therapy

1 reference

https://api.crossref.org/works/10.1186%2F1546-0096-9-30

21 January 2018

Mizoribine: mode of action and effects in clinical use.

1 reference

https://api.crossref.org/works/10.1186%2F1546-0096-9-30

21 January 2018

Efficacy of multidrug therapy combined with mizoribine in children with diffuse IgA nephropathy in comparison with multidrug therapy without mizoribine and with methylprednisolone pulse therapy

1 reference

https://api.crossref.org/works/10.1186%2F1546-0096-9-30

21 January 2018

Combination therapy with mizoribine for severe childhood IgA nephropathy: a pilot study

1 reference

https://api.crossref.org/works/10.1186%2F1546-0096-9-30

21 January 2018

Nephrotic syndrome and mizoribine in children.

1 reference

https://api.crossref.org/works/10.1186%2F1546-0096-9-30

21 January 2018

Treatment with the purine synthesis inhibitor mizoribine for ANCA-associated renal vasculitis

1 reference

https://api.crossref.org/works/10.1186%2F1546-0096-9-30

21 January 2018

High-dose mizoribine therapy for childhood-onset frequently relapsing steroid-dependent nephrotic syndrome with cyclosporin nephrotoxicity

1 reference

https://api.crossref.org/works/10.1186%2F1546-0096-9-30

21 January 2018

Histopathological features of murine systemic vasculitis caused by Candida albicans extract--an animal model of Kawasaki disease

1 reference

https://api.crossref.org/works/10.1186%2F1546-0096-9-30

21 January 2018

Induction of coronary arteritis with administration of CAWS (Candida albicans water-soluble fraction) depending on mouse strains.

1 reference

https://api.crossref.org/works/10.1186%2F1546-0096-9-30

21 January 2018

Mizoribine reduces renal injury and macrophage infiltration in non-insulin-dependent diabetic rats

1 reference

https://api.crossref.org/works/10.1186%2F1546-0096-9-30

21 January 2018

Contrasting effects of steroids and mizoribine on macrophage activation and glomerular lesions in rat thy-1 mesangial proliferative glomerulonephritis

1 reference

https://api.crossref.org/works/10.1186%2F1546-0096-9-30

21 January 2018

Reduction of MPO-ANCA epitopes in SCG/Kj mice by 15-deoxyspergualin treatment restricted by IgG2b associated with crescentic glomerulonephritis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3239324

25 September 2018

Susceptibility loci to coronary arteritis in animal model of Kawasaki disease induced with Candida albicans -derived substances

1 reference

https://pubmed.ncbi.nlm.nih.gov/21958311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Trial of prevention of coronary aneurysm in Kawasaki's disease using plasma exchange or infusion of immunoglobulins]

1 reference

https://pubmed.ncbi.nlm.nih.gov/21958311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High concentrations of interleukin-8 and monocyte chemoattractant protein-1 in urine of patients with acute Kawasaki disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/21958311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Administration of human immunoglobulin suppresses development of murine systemic vasculitis induced with Candida albicans water-soluble fraction: an animal model of Kawasaki disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/21958311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical pharmacokinetic study of mizoribine in renal transplantation patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/21958311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dual inhibitory effect of bredinin

1 reference

https://pubmed.ncbi.nlm.nih.gov/21958311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High-dose intravenous gammaglobulin for Kawasaki disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/21958311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy of plasma exchange therapy for Kawasaki disease intractable to intravenous gamma-globulin

1 reference

https://pubmed.ncbi.nlm.nih.gov/21958311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Infliximab for Kawasaki syndrome

1 reference

https://pubmed.ncbi.nlm.nih.gov/21958311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Initial intravenous gammaglobulin treatment failure in Kawasaki disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/21958311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Plasma exchange for refractory Kawasaki disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/21958311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Suppressive effect of mizoribine on humoral antibody production in DBA/2 mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/21958311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ulinastatin, an elastase inhibitor, inhibits the increased mRNA expression of prostaglandin H2 synthase-type 2 in Kawasaki disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/21958311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1186/1546-0096-9-30

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

Dimensions Publication ID

0 references

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35617543&oldid=1581698428"